ALYSSA KLOPFER: Open Payments
NPI 1568193431 · CAMP SPRINGS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,029 in 162 payments from 28 companies in 2025. Trend: 2023 $4,329 · 2024 $4,111 · 2025 $4,029
Food & beverage: $4,029
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 33 | $577 |
| Insulet Corporation | 8 | $433 |
| Novo Nordisk Inc | 18 | $406 |
| SANOFI-AVENTIS U.S. LLC | 13 | $330 |
| BETA BIONICS, INC. | 6 | $262 |
| Xeris Pharmaceuticals, Inc. | 9 | $215 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $198 |
| Amneal Pharmaceuticals LLC | 8 | $172 |
| Abbott Laboratories | 8 | $139 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $137 |
Products named: Omnipod, JARDIANCE, MOUNJARO, TZIELD, iLet Bionic Pancreas, Wegovy, UNITHROID, Ozempic.
Industry payments across MD — which companies pay providers there.
